Suchergebnisse

AbstractVarious processes in recent years have brought about trends of polarization within democratic societies, challenging political stability. Against this backdrop, policy patterns that are being adopted regarding controversial issues are significantly affected by these countries' aspiration to create and maintain a consensus, which may have implications not favoring the public. One such issue is human experiments in medicine (clinical trials), which has been regulated by most countries through primary legislation. As a deeply divided society, Israel has been addressing this issue through regulation and secondary legislation, despite several attempts to have it regulated through primary legislation. This article employs the consociational model alongside Public Choice Theory to explain the adoption of this policy pattern on the issue of human experiments. Based on thematic analysis of semi-structured interviews and existing sources, it sheds light on the normative choice that weighs the merits of primary legislation against the virtues of accommodation and consensus.